newsfilter
← Latest News
GlobeNewswire·

ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

LOS ANGELES, Dec. 20, 2023 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (NASDAQ:SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today